Double Medical Technology Inc Working Capital to Net Assets Ratio
Double Medical Technology Inc working capital to net assets ratio. Double Medical Technology Inc (002901) has a Working Capital to Net Assets ratio of 68.5% as of March 2026. Working capital of CN¥2.64 Billion (current assets of CN¥3.46 Billion minus current liabilities of CN¥817.23 Million) is measured against net assets of CN¥3.85 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Double Medical Technology Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Double Medical Technology Inc (2013–2025)
Working capital to net assets ratio of Double Medical Technology Inc from 2013 to 2025. This chart shows how Double Medical Technology Inc's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the ratio stands at 68.5%, reflecting working capital of CN¥2.64 Billion against net assets of CN¥3.85 Billion CNY. See Double Medical Technology Inc liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Double Medical Technology Inc Working Capital to Net Assets Ratio by Year (2013–2025)
Double Medical Technology Inc working capital to net assets ratio by year from 2013 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Double Medical Technology Inc from 2013 to 2025, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see how large is Double Medical Technology Inc's balance sheet.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 66.8% | CN¥2.46 Billion | CN¥3.69 Billion | CN¥3.34 Billion | CN¥878.18 Million | ▲ +8.0 pp |
| 2024 | 58.8% | CN¥1.87 Billion | CN¥3.18 Billion | CN¥2.81 Billion | CN¥941.40 Million | ▼ -4.5 pp |
| 2023 | 63.3% | CN¥2.00 Billion | CN¥3.16 Billion | CN¥3.16 Billion | CN¥1.15 Billion | ▼ -1.4 pp |
| 2022 | 64.7% | CN¥2.01 Billion | CN¥3.11 Billion | CN¥2.73 Billion | CN¥716.60 Million | ▲ +0.0 pp |
| 2021 | 64.6% | CN¥1.67 Billion | CN¥2.59 Billion | CN¥2.40 Billion | CN¥721.78 Million | ▼ -6.9 pp |
| 2020 | 71.6% | CN¥1.53 Billion | CN¥2.13 Billion | CN¥1.97 Billion | CN¥446.00 Million | ▲ +1.9 pp |
| 2019 | 69.7% | CN¥1.22 Billion | CN¥1.75 Billion | CN¥1.65 Billion | CN¥425.75 Million | ▼ -9.6 pp |
| 2018 | 79.2% | CN¥1.16 Billion | CN¥1.46 Billion | CN¥1.33 Billion | CN¥176.55 Million | ▼ -0.7 pp |
| 2017 | 80.0% | CN¥990.52 Million | CN¥1.24 Billion | CN¥1.11 Billion | CN¥117.80 Million | ▲ +20.5 pp |
| 2016 | 59.5% | CN¥345.15 Million | CN¥580.13 Million | CN¥452.24 Million | CN¥107.09 Million | ▲ +10.8 pp |
| 2015 | 48.7% | CN¥215.23 Million | CN¥441.78 Million | CN¥300.56 Million | CN¥85.33 Million | ▲ +20.1 pp |
| 2014 | 28.7% | CN¥78.61 Million | CN¥274.36 Million | CN¥337.89 Million | CN¥259.28 Million | ▼ -25.6 pp |
| 2013 | 54.2% | CN¥121.82 Million | CN¥224.61 Million | CN¥186.59 Million | CN¥64.77 Million | — |